These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 27123891)

  • 1. Nucleosome Assembly Alters the Accessibility of the Antitumor Agent Duocarmycin B2 to Duplex DNA.
    Zou T; Kizaki S; Pandian GN; Sugiyama H
    Chemistry; 2016 Jun; 22(26):8756-8. PubMed ID: 27123891
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Investigating Nucleosome Accessibility for MNase, Fe
    Zou T; Kizaki S; Sugiyama H
    Chembiochem; 2018 Apr; 19(7):664-668. PubMed ID: 29334166
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alkylation of duplex DNA in nucleosome core particles by duocarmycin SA and yatakemycin.
    Trzupek JD; Gottesfeld JM; Boger DL
    Nat Chem Biol; 2006 Feb; 2(2):79-82. PubMed ID: 16415862
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficient guanine alkylation through cooperative heterodimeric formation of duocarmycin A and distamycin A.
    Isomura M; Sugiyama H; Saito I
    Nucleic Acids Symp Ser; 1995; (34):47-8. PubMed ID: 8841545
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sequence-specific alkylation of DNA by duocarmycin A and its novel derivatives bearing PY/IM polyamides.
    Tao ZF; Fujiwara T; Saito I; Sugiyama H
    Nucleosides Nucleotides; 1999; 18(6-7):1615-6. PubMed ID: 10474238
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Concerted DNA recognition and novel site-specific alkylation by duocarmycin A with distamycin A.
    Yamamoto K; Sugiyama H; Kawanishi S
    Biochemistry; 1993 Feb; 32(4):1059-66. PubMed ID: 8424935
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and evaluation of N-aryl and N-alkenyl CBI derivatives.
    Parrish JP; Trzupek JD; Hughes TV; Hwang I; Boger DL
    Bioorg Med Chem; 2004 Nov; 12(22):5845-56. PubMed ID: 15498660
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Site specific covalent alkylation of DNA by antitumor antibiotics, duocarmycin A and kapurimycin A3.
    Sugiyama H; Lam CK; Hosoda M; Saito I
    Nucleic Acids Symp Ser; 1991; (25):75-6. PubMed ID: 1842103
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Binding free energy calculation for duocarmycin/DNA complex based on the QPLD-derived partial charge model.
    Zhong H; Kirschner KN; Lee M; Bowen JP
    Bioorg Med Chem Lett; 2008 Jan; 18(2):542-5. PubMed ID: 18083559
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cooperative alkylation by duocarmycin A-distamycin A heterodimer.
    Ozeki Y; Sugiyama H; Saito I
    Nucleic Acids Symp Ser; 1997; (37):91-2. PubMed ID: 9586014
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sequence-selective guanine reactivity by duocarmycin A.
    Mitchell MA; Weiland KL; Aristoff PA; Johnson PD; Dooley TP
    Chem Res Toxicol; 1993; 6(4):421-4. PubMed ID: 8374036
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sequence specificity, reactivity, and antitumor activity of DNA-alkylating pyrrole-imidazole diamides.
    Bando T; Iida H; Tao ZF; Narita A; Fukuda N; Yamori T; Sugiyama H
    Chem Biol; 2003 Aug; 10(8):751-8. PubMed ID: 12954334
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design, Synthesis, and Evaluation of Linker-Duocarmycin Payloads: Toward Selection of HER2-Targeting Antibody-Drug Conjugate SYD985.
    Elgersma RC; Coumans RG; Huijbregts T; Menge WM; Joosten JA; Spijker HJ; de Groot FM; van der Lee MM; Ubink R; van den Dobbelsteen DJ; Egging DF; Dokter WH; Verheijden GF; Lemmens JM; Timmers CM; Beusker PH
    Mol Pharm; 2015 Jun; 12(6):1813-35. PubMed ID: 25635711
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Establishing the parabolic relationship between reactivity and activity for derivatives and analogues of the duocarmycin and CC-1065 alkylation subunits.
    Parrish JP; Hughes TV; Hwang I; Boger DL
    J Am Chem Soc; 2004 Jan; 126(1):80-1. PubMed ID: 14709069
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distamycin A modulates the sequence specificity of DNA alkylation by duocarmycin A.
    Sugiyama H; Lian C; Isomura M; Saito I; Wang AH
    Proc Natl Acad Sci U S A; 1996 Dec; 93(25):14405-10. PubMed ID: 8962064
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Establishment of substituent effects in the DNA binding subunit of CBI analogues of the duocarmycins and CC-1065.
    Parrish JP; Kastrinsky DB; Stauffer F; Hedrick MP; Hwang I; Boger DL
    Bioorg Med Chem; 2003 Aug; 11(17):3815-38. PubMed ID: 12901927
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Solution structure of the covalent duocarmycin A-DNA duplex complex.
    Lin CH; Patel DJ
    J Mol Biol; 1995 Apr; 248(1):162-79. PubMed ID: 7731041
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CC-1065 and the duocarmycins: unraveling the keys to a new class of naturally derived DNA alkylating agents.
    Boger DL; Johnson DS
    Proc Natl Acad Sci U S A; 1995 Apr; 92(9):3642-9. PubMed ID: 7731958
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Duocarmycins binding to DNA investigated by molecular simulation.
    Spiegel K; Rothlisberger U; Carloni P
    J Phys Chem B; 2006 Mar; 110(8):3647-60. PubMed ID: 16494420
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Solid-Phase Synthesis of Duocarmycin Analogues and the Effect of C-Terminal Substitution on Biological Activity.
    Stephenson MJ; Howell LA; O'Connell MA; Fox KR; Adcock C; Kingston J; Sheldrake H; Pors K; Collingwood SP; Searcey M
    J Org Chem; 2015 Oct; 80(19):9454-67. PubMed ID: 26356089
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.